FDA warned American Cleaning Solutions after a 2022 inspection found hand sanitizer made with inadequate cleaning, unvalidated processes, and substituted ethanol.
What happened
FDA inspected the Long Island City, NY drug manufacturing facility from March 7 to March 28, 2022. Investigators found inadequate cleaning and maintenance of equipment also used for pesticides and industrial cleaners, no process validation or equipment qualification, missing incoming component testing, and weak quality-control oversight. FDA also found Secure Hand Sanitizer labeled as 70% isopropyl alcohol had been made with ethanol, and cited repeat observations from a 2016 inspection.
What FDA found
The company lacked adequate written cleaning and maintenance procedures and had rust, dirt, debris, and grease on drug manufacturing equipment.
21 CFR 211.67(b)The company had not validated its hand sanitizer manufacturing processes or qualified its equipment, and batch records did not match the formulation.
21 CFR 211.100(a) and (b)The company did not test incoming components for identity and did not qualify suppliers or verify their certificates of analysis.
21 CFR 211.84(d)(1) and (2)The quality-control group failed to ensure active-ingredient testing before release, investigations, change documentation, stability testing, and annual product reviews.
21 CFR 211.22; 211.165(a); 211.192; 211.100(a); 211.166(a); 211.180(e)Secure Hand Sanitizer labeled as 70% isopropyl alcohol contained ethanol, substituting the active ingredient.
FD&C Act section 501(d)(2)
What FDA wants
FDA tells the company to correct the violations promptly and respond in writing within 15 working days with corrective actions and prevention plans, or explain any delay and provide a completion schedule. If it resumes drug manufacturing, it must notify FDA before resuming.
Who should pay attention
- brands or retailers that buy OTC hand sanitizer from contract manufacturers
- suppliers of ethanol or isopropanol to drug manufacturers
- quality teams at facilities that share equipment between drugs and industrial chemicals
This is a summary. Read the original letter on fda.gov.